U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 4C6H5O7.3Mo
Molecular Weight 1044.22
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MOLYBDENUM CITRATE

SMILES

[Mo+4].[Mo+4].[Mo+4].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

InChI

InChIKey=YNNQORGFPVDZOI-UHFFFAOYSA-B
InChI=1S/4C6H8O7.3Mo/c4*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h4*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;;;3*+4/p-12

HIDE SMILES / InChI

Molecular Formula Mo
Molecular Weight 95.94
Charge 4
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C6H5O7
Molecular Weight 189.0997
Charge -3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molybdenum (Mo) is an essential trace element and is a component of vitamin and mineral supplements. Molybdenum has essential biological roles in organisms and microorganisms. Molybdenum is the only trace metal of the second row of the periodic table that exhibits biological activity when it is ligated to a cofactor. It acts as a critical cofactor in several molybdenum-dependent enzymes that are involved in important cellular reactions and pathways, including xanthine oxidoreductase. In nature two principal concepts of Mo cofactors have evolved, one is the iron Mo cofactor in bacterial nitrogenase and the other is represented by a large family of enzymes with more than 100 representatives relying on the pterin-based Mo cofactor (Moco). Moco-containing enzymes catalyze key redox reactions in the global carbon, sulfur and nitrogen cycles. Four molybdenum-dependent enzymes are known in humans, each harboring a pterin-based molybdenum cofactor (Moco) in the active site. In these enzymes, molybdenum catalyzes oxygen transfer reactions from or to substrates using water as oxygen donor or acceptor. Molybdenum shuttles between two oxidation states, Mo(IV) and Mo(VI). Following substrate reduction or oxidation, electrons are subsequently shuttled by either inter- or intra-molecular electron transfer chains involving prosthetic groups such as heme or iron-sulfur clusters. In all organisms studied so far, Moco is synthesized by a highly conserved multi-step biosynthetic pathway. A deficiency in the biosynthesis of Moco results in a pleitropic loss of all four human Mo-enzyme activities and in most cases in early childhood death. For the general population, the diet is the most important source of molybdenum and concentrations in water and air usually are negligible. The average daily dietary intake is about 0.1-0.5 mg m.o. Molybdenum is marketed both as a tablet and as a liquid supplement containing the mineral in dissolved form. Despite widespread claims, there is no evidence that one form of molybdenum is absorbed to a markedly superior extent than any other. Current marketing of molybdenum products for the treatment of medical conditions is not founded on any meaningful scientific evidence. People with serious kidney disease should avoid taking molybdenum (or any other supplement) except on the advice of a physician. People with serious kidney disease should also avoid taking molybdenum (or any other supplement) except on the advice of a physician.

Approval Year

PubMed

PubMed

TitleDatePubMed
Molecular basis of proton motive force generation: structure of formate dehydrogenase-N.
2002 Mar 8
Possible effects of metallosis on spermatozoal apoptotic genes expression in individuals with intramedullary nailing prosthesis.
2014 Jun
Study of antitumor effect of selected vanadium and molybdenum organometallic complexes in human leukemic T-cells.
2015 Dec 5
The Co-induced Effects of Molybdenum and Cadmium on Antioxidants and Heat Shock Proteins in Duck Kidneys.
2015 Nov
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Dietary Considerations Dietary reference intake (IOM, 2011): 0 to 6 months: Adequate intake: 2 mcg daily 7 to 12 months: Adequate intake: 3 mcg daily 1 to 3 years: RDA: 17 mcg daily 4 to 8 years: RDA: 22 mcg daily 9 to 13 years: RDA: 34 mcg daily ≥14 to 18 years: RDA: 43 mcg daily >18 years: RDA: 45 mcg daily Pregnancy and lactation: RDA: 50 mcg daily
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 19:10:23 GMT 2023
Edited
by admin
on Sat Dec 16 19:10:23 GMT 2023
Record UNII
BQ2CRB3TW9
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MOLYBDENUM CITRATE
Common Name English
Molybdenum citrate [WHO-DD]
Common Name English
Code System Code Type Description
CAS
74873-24-8
Created by admin on Sat Dec 16 19:10:23 GMT 2023 , Edited by admin on Sat Dec 16 19:10:23 GMT 2023
NON-SPECIFIC STOICHIOMETRY
PUBCHEM
129690653
Created by admin on Sat Dec 16 19:10:23 GMT 2023 , Edited by admin on Sat Dec 16 19:10:23 GMT 2023
PRIMARY
FDA UNII
BQ2CRB3TW9
Created by admin on Sat Dec 16 19:10:23 GMT 2023 , Edited by admin on Sat Dec 16 19:10:23 GMT 2023
PRIMARY
SMS_ID
100000184289
Created by admin on Sat Dec 16 19:10:23 GMT 2023 , Edited by admin on Sat Dec 16 19:10:23 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY
ACTIVE MOIETY